{"agency": "Health and Human Sevices", "agency_short": "HHS", "published": "2014-07-28T00:00:00", "title": "AO 14-05", "url": "https://oig.hhs.gov/compliance/advisory-opinions/14-05/", "attachments": [{"title": "Advisory Opinion 14-05", "url": "https://oig.hhs.gov/documents/advisory-opinions/683/AO-14-05.pdf", "mimetype": "application/pdf"}], "classification": "advisory-opinion", "identifier": "HHS-OIG-AO-14-05", "subagency": "Office of the Inspector General", "summary": "Concerning a pharmaceutical manufacturer's direct-to-patient product sales program that allows eligible patients to purchase one of the manufacturer's brand-name products for a fixed cash price from an online retail pharmacy vendor outside of any applicable prescription drug insurance benefit."}